Danish Cannabis Company Stenocare To Launch ‘Innovative’ Medical Marijuana Oil In Germany
A publicly traded Danish medical marijuana operator Stenocare and German cannabis-focused pharma company ADREXpharma are ready to deliver a new and innovative medical cannabis oil for German patients.
The companies obtained approval to sell new medical marijuana oil in Germany, with first sales expected in the fourth quarter of 2024.
“Our Astrum 10-10 oil was first approved for sales in Australia and now we are adding Germany as the second market,”CEO of Stenocare, Thomas Skovlund Schnegelsberg stated. “In our opinion, the new Astrum product is truly groundbreaking for the entire industry of medical cannabis and for the German patients. In short, our new oil technology address key challenges in the industry of medical cannabis: 1) It doubles the uptake of cannabinoid, 2) It delivers a uniform uptake in the blood across individuals, 3) the maximum concentration …